Welcome. If you're a registered user, please log-in. If not, please sign-up.

       CPD Accredited

CMC Analytical, Comparability and Stability Studies for Biotechnology and Biosimilar Products Training Course

Key Topics Include...

Biotechnology CMC Regulatory Requirements

Biotechnology Product Specifications; Comparability and Stability Issues

Biotechnology Analytical Methodology

Implementation of Biotechnology Laboratory Tests

Discussion of Ongoing Resources for Biotechnology Analytical CMC Issues

Course Objectives

This course will provide attendees with a concise but comprehensive overview of all relevant regulatory, technical and quality elements necessary to assure successful design, implementation and documentation of the required CMC analytical and stability studies for biotechnology products, including biosimilar products.Key deliverables from each phase of development will be illustrated. Current ‘hot-button’ CMC analytical and stability issues will be presented, and strategies for preventing (or remediating) gaps will be presented.

Attendees will be given a USB drive containing a complete set of all regulatory documents and industry white papers currently applicable to biotechnology product analytical CMC requirements that covers the entire product development lifecycle.

Media Partners


Dates and Venues

01 Oct 2015 - 02 Oct 2015

Radisson Blu Edwardian Grafton, London

Performance and Knowledge Objectives

  • Gain a comprehensive overview of the phase-specific requirements for CMC analytical characterisation, comparability, release and stability of biotechnology products
  • Examine the different stages of the lifecycle including pre-clinical, clinical trials, commercialisation and post-approval
  • Discuss analytical considerations for a wide variety of biopharmaceuticals including monoclonal antibodies, therapeutic proteins, gene therapy, vaccines, and complex products (e.g. antibody drug conjugates)
  • Maintain product reference standards and design successful comparability tests
  • Design and implement successful comparability tests for biosimilars
  • Learn to set meaningful product specifications, conduct forced degradation studies and manage tech transfer
  • Bridge changes in analytical methods and generate effective stability protocols
  • Assess critical elements of laboratory quality practices that significantly impact the reliability of test data from R&D through to current GMP will be illustrated

Why you should attend

  • Create compliant stability protocols
  • Ensure EU and FDA regulatory compliance
  • Identify specifications for release

Download Latest Information Now

(updated 1 October 2015)

Latest Updates

BioProcess Special Report - Recommendations for Cell Banks Used in GXP Assays

Download here:http://www.pti-global.co.uk/event/stabilitybiotech/download/?id=10458


BioProcess Technical: Stability Considerations for Biopharmaceuticals, Part 1

Download here:http://www.pti-global.co.uk/event/stabilitybiotech/download/?id=10459

Follow us on Twitter


Connect with the PTI faculty! PTI is a global pharmaceutical training company with over 60 interctive courses focusing on Regulatory Affairs, R&D, Clinical, Business Strategy, Fine Chemicals, Biopharmaceuticals, Manufacturing, Medical Devices and Agrochemicals 

Other Events That Will Interest You

Comparability for Biologics

03 Dec 2015 - 04 Dec 2015
Radisson Blu Royal Hotel Dublin

Analysing Bioassays and Immunoassays

03 Nov 2015 - 04 Nov 2015
Radisson Blu Edwardian Grafton, London

PTI is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.